|
|
Therapeutic effect of laparoscopic minimally invasive surgery combined with ezetimibe against cholecystolithiasis and its influence on serum CCK-A and SREBP-2 levels |
QIU Fuchun, LI Min, WANG Lu, WEI Wenpeng |
Department of Peritoneal Oncology, Beijing ShiJitan Hospital,Beijing 100038,China |
|
|
Abstract Objective To investigate the efficacy of laparoscopic minimally invasive surgery combined with ezetimibe in the treatment of cholecystolithiasis and its influence on serum CCK-A and SREBP-2 levels.Methods A total of 120 patients with gallstones diagnosed in our hospital between August 2016 and August 2018) were selected and divided into the experimental group and control group using the random envelope method and according to the admission time, with 60 cases in each group.The control group underwent three-port laparoscopic choledochoscopic cholelithotripsy while the experimental group received ezetimibe as well as laparoscopic minimally invasive surgery. The curative effect was evaluated according to the clinical symptoms and signs of the patients. The number and diameter of gallstones were examined before and after treatment, and the expression levels of TNF, IL-1, CCK-A and SREBP-2 were detected.Results The effective rate was 93.33% in the experimental group and 76.67% in the control group. There was no significant difference in the number and diameter of gallstones between the two groups before treatment (P>0.05). After treatment, the number and diameter of gallstones in both groups decreased. They were smaller in the experimental group than in the control group (P<0.05). There was no significant difference in serum levels of TNF, IL-1, CCK-A and SREBP-2 between the two groups before treatment. After treatment, serum levels of TNF, IL-1 and SREBP-2 decreased while CCK-A increased in the two groups, espeically in the experimental group (P<0.05).There was no significant difference in the gallstone diameter between the two groups before treatment. After treatment, the number and diameter of gallstones in both groups decreased, and the diameter of gallstones in the experimental group was smaller than that in the control group (P< 0.05).The incidence of adverse reactions was 10.00% in the experimental group and 6.67% in the control group, but the difference was of no statistical significance.Conclusions Ezetimibe combined with laparoscopic minimally invasive surgery can significantly alleviate the clinical symptoms of patients, prevent and slow down the formation of gallstones, alleviate inflammation, reduce cholesterol absorption, and restore gallbladder contractile function.
|
Received: 02 January 2019
|
|
|
|
|
[1] |
Vítek L, Carey M C. New pathophysiological concepts underlying pathogenesis of pigment gallstones[J]. Clin Res Hepatol Gastroenterol, 2012, 36(2):122-129.
|
[2] |
Lu J, Cheng Y,Xiong X Z, et al. Two-stage vs single-stage management for concomitant gallstones and common bile duct stones.[J]. World J Gastroenterol, 2012, 18(24):3156-3166.
|
[3] |
贺 岩, 陈 辉, 李 燕,等. 血脂水平与胆囊胆固醇性结石、息肉的关系[J]. 宁夏医科大学学报, 2017, 39(5):568-570.
|
[3] |
郭怀斌, 潘 毓, 暴 雷,等. 瘦素对血脂及胆汁成分的调节在胆囊胆固醇结石形成中的作用[J]. 中国普通外科杂志, 2018 (2):204-209.
|
[4] |
刘晓丽, 赵 琦, 李 云, 等. SREBP-2基因多态与胆固醇水平的关联研究[J]. 中国分子心脏病学杂志, 2008, 8(4):203-207.
|
[5] |
许焕建, 任培土, 邵惠江,等. 微创保胆取石前后血脂、血瘦素及胆囊收缩素水平的变化[J]. 中国内镜杂志, 2016, 22(1):15-18.
|
[6] |
李军祥, 陈 誩,梁 健. 胆石症中西医结合诊疗共识意见(2017年)[J]. 中国中西医结合消化杂志, 2018,26(2):132-138.
|
[7] |
张亮亮,脱红芳.肝硬化并胆囊结石的病理改变与发病机制[J]. 中国普通外科杂志, 2016, 25(2):276-280.
|
[8] |
朱 亚. 胆囊结石合并胆总管结石精准治疗的临床研究[D].昆明:昆明医科大学,2017.
|
[9] |
李凯琅, 孙登群, 周章韵,等. 改良两孔法腹腔镜胆囊切除术115例[J]. 武警医学, 2017, 28(12):1276-1276.
|
[10] |
刘益民, 金上博, 闫耀生,等. 依泽替米贝对胆囊结石患者血清TNF及IL-1水平影响[J]. 现代生物医学进展, 2015, 15(28):5512-5515.
|
[11] |
Swindle J P, Ye X, Mallick R, et al. Colesevelam ezetimibe, and patients with type 2 diabetes mellitus: characteristics and clinical outcomes from a health care database[J]. Annals Pharmacother, 2014, 48(7):847-855.
|
[12] |
闫长红,许艳春.腹腔镜胆囊切除术对患者血清IL-6、IL-10、TNF-α水平的影响[J].宁夏医科大学学报,2016,38(4):469-471.
|
[13] |
陈长生. 辛伐他汀联合依泽替米贝治疗冠心病伴高脂血症的临床疗效及对改善血管内皮功能的影响[J]. 现代诊断与治疗, 2017, 28(9):1644-1645.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(11): 1171-1172. |
|
|
|
|